Gilead Sciences
Foster City, California, United States
Daniel O'Day
Board Member
San Francisco Bay, United States of America
Working with Gilead employees around the world to create new possibilities in medicine. Delivering on our long term commitment to groundbreaking science and access so we can help make the world a better, healthier place.
- Work History
Georgetown University
3 years, 1 month- Board Member
- Jul 2023 - Present
Gilead Sciences
7 years, 5 months- Chairman and Chief Executive Officer
- Mar 2019 - Present
PhRMA
7 years, 5 months- Board Member
- Mar 2019 - Present
Galapagos
4 years, 3 months- Board Member
- Oct 2019 - Jan 2024
Roche
32 years- Chief Executive Officer, Roche Pharmaceuticals
- Jan 2016 - Jan 2019
- Chief Operating Officer, Pharma Division
- Jan 2012 - Jan 2016
- Chief Operating Officer, Diagnostics Division
- Jan 2010 - Jan 2012
- President and Chief Executive Officer, Molecular Diagnostics (RMD)
- Jan 2006 - Jan 2010
- General Manager, Denmark, Roche Pharma
- Jan 2003 - Jan 2006
- Head, Corporate Planning, Nippon Roche KK (Japan)
- Jan 2001 - Jan 2003
- Lifecycle Leader, Tamiflu
- Jan 1999 - Jan 2001
- Head Business Unit, Arthritis and Respiratory
- Jan 1998 - Jan 1999
- Director, Product Marketing, U.S.
- Jan 1996 - Jan 1998
- Director, Human Resources
- Jan 1995 - Jan 1996
- Commercial Sales
- Jan 1987 - Jan 1995
Executives


Cindy Perettie
Executive Vice President at Global Head of Kite


Chris McDonald
Global Head of Technical Operations at Kite
Veronica Jones
Chief Procurement Officer


